CELLULAR HEMOGLOBIN A1C QUALITY CONTROLS
    11.
    发明申请
    CELLULAR HEMOGLOBIN A1C QUALITY CONTROLS 审中-公开
    细胞HEMOGLOBIN A1C质量控制

    公开(公告)号:US20140134597A1

    公开(公告)日:2014-05-15

    申请号:US14062351

    申请日:2013-10-24

    CPC classification number: G01N33/721 G01N33/5094

    Abstract: Intact erythrocytes with selected and often elevated levels of hemoglobin A1c (HbA1c) for use as quality controls for HbA1c assays and assay instruments are prepared by hypotonic dialysis of erythrocytes from a healthy mammal to permeabilize the erythrocyte membranes, infusion of the permeabilized erythrocytes with hemoglobin A1c, and de-permeabilization of the infused erythrocytes. Quality controls of essentially any level of HbA1c can be prepared in this manner and once prepared will be useful for monitoring the entire assay procedure, including the lysis of the erythrocytes in a typical sample.

    Abstract translation: 通过对来自健康哺乳动物的红细胞进行低渗透析以透过红细胞膜,用血红蛋白A1c输注透化的红细胞,制备具有选定且经常升高的血红蛋白A1c(HbA1c)水平的完整红细胞,用于HbA1c测定和测定仪器的质量控制 ,以及输注红细胞的不透性化。 可以以这种方式制备基本上任何水平的HbA1c的质量控制,一旦制备将用于监测整个测定程序,包括典型样品中红细胞的裂解。

Patent Agency Ranking